Viewing Study NCT03109158


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-01-06 @ 5:51 AM
Study NCT ID: NCT03109158
Status: COMPLETED
Last Update Posted: 2019-04-29
First Post: 2017-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: NanoCarrier Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module